Goals of Treatment for Type 2 Diabetes β-Cell preservation for glycemic control

被引：48

作者：

Marchetti, Piero ^{[1
]}

Lupi, Roberto ^{[1
]}

Del Guerra, Silvia ^{[1
]}

Bugliani, Marco ^{[1
]}

D'Aleo, Valentina ^{[1
]}

Occhipinti, Margherita ^{[1
]}

Boggi, Ugo ^{[1
]}

Marselli, Lorella ^{[1
]}

Masini, Matilde ^{[1
]}

机构：

[1] Univ Pisa, Dept Endocrinol & Metab, Pisa, Italy

来源：

DIABETES CARE | 2009年 / 32卷

关键词：

HUMAN PANCREATIC-ISLETS; LIFE-STYLE INTERVENTION; INSULIN-RESISTANCE; GLUCOSE-TOLERANCE; C-PEPTIDE; METFORMIN; MELLITUS; MASS; DYSFUNCTION; SECRETION;

D O I：

10.2337/dc09-S306

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：S178 / S183

页数：6

共 48 条

[1] Diagnosis and classification of diabetes mellitus [J].

DIABETES CARE, 2008, 31 :S55-S60

[2]

[Anonymous], 1995, Diabetes, V44, P1249

[3] Preservation of pancreatic β-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk Hispanic women [J].

Buchanan, TA ;

Xiang, AH ;

Peters, RK ;

Kjos, SL ;

Marroquin, A ;

Goico, J ;

Ochoa, C ;

Tan, S ;

Berkowitz, K ;

Hodis, HN ;

Azen, SP .

DIABETES, 2002, 51 (09) :2796-2803

[4] Effects of C-peptide on isolated human pancreatic islet cells [J].

Bugliani, Marco ;

Torri, Scilla ;

Lupi, Roberto ;

Del Guerra, Silvia ;

Grupillo, Maria ;

Del Chiaro, Marco ;

Mosca, Franco ;

Boggi, Ugo ;

Del Prato, Stefano ;

Marchetti, Piero .

DIABETES-METABOLISM RESEARCH AND REVIEWS, 2007, 23 (03) :215-219

[5] One-year Treatment With Exenatide Improves β-Cell Function, Compared With Insulin Glargine, in Metformin-Treated Type 2 Diabetic Patients A randomized, controlled trial [J].

Bunck, Mathijs C. ;

Diamant, Michaela ;

Corner, Anja ;

Eliasson, Bjorn ;

Malloy, Jaret L. ;

Shaginian, Rimma M. ;

Deng, Wei ;

Kendall, David M. ;

Taskinen, Marja-Riitta ;

Smith, Ulf ;

Yki-Jarvinen, Hannele ;

Heine, Robert J. .

DIABETES CARE, 2009, 32 (05) :762-768

[6] β-cell deficit and increased β-cell apoptosis in humans with type 2 diabetes [J].

Butler, AE ;

Janson, J ;

Bonner-Weir, S ;

Ritzel, R ;

Rizza, RA ;

Butler, PC .

DIABETES, 2003, 52 (01) :102-110

[7] Progressive loss of β-cell function leads to worsening glucose tolerance in first-degree relatives of subjects with type 2 diabetes [J].

Cnop, Miriam ;

Vidal, Josep ;

Hull, Rebecca L. ;

Utzschneider, Kristina M. ;

Carr, Darcy B. ;

Schraw, Todd ;

Scherer, Philipp E. ;

Boyko, Edward J. ;

Fujimoto, Wilfred Y. ;

Khan, Steven E. .

DIABETES CARE, 2007, 30 (03) :677-682

[8] Functional and molecular defects of pancreatic islets in human type 2 diabetes [J].

Del Guerra, S ;

Lupi, R ;

Marselli, L ;

Masini, M ;

Bugliani, M ;

Sbrana, S ;

Torri, S ;

Pollera, M ;

Boggi, U ;

Mosca, F ;

Del Prato, S ;

Marchetti, P .

DIABETES, 2005, 54 (03) :727-735

[9] Structural and functional abnormalities in the islets isolated from type 2 diabetic subjects [J].

Deng, SP ;

Vatamaniuk, M ;

Huang, XL ;

Doliba, N ;

Lian, MM ;

Frank, A ;

Velidedeoglu, E ;

Desai, NM ;

Koeberlein, B ;

Wolf, B ;

Barker, CF ;

Naji, A ;

Matschinsky, FM ;

Markmann, JF .

DIABETES, 2004, 53 (03) :624-632

[10] The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes [J].

Drucker, Daniel J. ;

Nauck, Michael A. .

LANCET, 2006, 368 (9548) :1696-1705

← 1 2 3 4 5 →